Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voriconazole concentrations: Inhalation vs Oral
NCT02396225Terminated
- Sponsor
- Aarhus University
- Start
- Mar 2015
- Primary completion
- Dec 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of voriconazole in invasive aspergillosis (IA), sponsored by Aarhus University. Started Mar 2015; status: terminated.
02
Drugs
voriconazole
03
Conditions
invasive aspergillosis (IA)
Beyond the preview
Go deeper on NCT02396225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396225.